Abstract
The optimization and kinetic of rosmarinic acid extraction from Orthosiphon stamineus were investigated in this study. In the preliminary study, the extractions were carried out to identify the optimal ethanol concentration. Then, the optimal ethanol concentration was used to optimize the extraction variables (solventto- solid loading ratio, temperature and time) by central composite design. The optimum conditions for the rosmarinic acid extraction were at the concentration of ethanol, 70% v/v; solvent-to-solid loading ratio, 9.14; extraction temperature, 56.53°C; and extraction time, 3 hours. Subsequently, this study used six proposed models to describe the kinetic of the rosmarinic acid extraction. Two-site kinetic model gave the best fit for the experimental data with the highest coefficient of determination, R2 (0.976) and the smallest values of root mean square error (RMSE) (1.522). The goodness of fit is due to the presence of the rate constants of both fast and slow released fractions in the model. Hence, two-site kinetic model is the most appropriate model to describe the rosmarinic acid extraction from O. stamineus in a reflux extraction system.
Keywords: Central Composite design, extraction, kinetic modeling, Orthosiphon stamineus, response surface methodology, rosmarinic acid.
Current Bioactive Compounds
Title:Optimization and Kinetic Modeling of Rosmarinic Acid Extraction from Orthosiphon stamineus
Volume: 10 Issue: 4
Author(s): Cher H. Lau, Lee S. Chua, Chew T. Lee and Ramlan Aziz
Affiliation:
Keywords: Central Composite design, extraction, kinetic modeling, Orthosiphon stamineus, response surface methodology, rosmarinic acid.
Abstract: The optimization and kinetic of rosmarinic acid extraction from Orthosiphon stamineus were investigated in this study. In the preliminary study, the extractions were carried out to identify the optimal ethanol concentration. Then, the optimal ethanol concentration was used to optimize the extraction variables (solventto- solid loading ratio, temperature and time) by central composite design. The optimum conditions for the rosmarinic acid extraction were at the concentration of ethanol, 70% v/v; solvent-to-solid loading ratio, 9.14; extraction temperature, 56.53°C; and extraction time, 3 hours. Subsequently, this study used six proposed models to describe the kinetic of the rosmarinic acid extraction. Two-site kinetic model gave the best fit for the experimental data with the highest coefficient of determination, R2 (0.976) and the smallest values of root mean square error (RMSE) (1.522). The goodness of fit is due to the presence of the rate constants of both fast and slow released fractions in the model. Hence, two-site kinetic model is the most appropriate model to describe the rosmarinic acid extraction from O. stamineus in a reflux extraction system.
Export Options
About this article
Cite this article as:
H. Lau Cher, S. Chua Lee, T. Lee Chew and Aziz Ramlan, Optimization and Kinetic Modeling of Rosmarinic Acid Extraction from Orthosiphon stamineus, Current Bioactive Compounds 2014; 10 (4) . https://dx.doi.org/10.2174/157340721004150206151452
DOI https://dx.doi.org/10.2174/157340721004150206151452 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Emerging Features in the Regulation of MMP-9 Gene Expression for the Development of Novel Molecular Targets and Therapeutic Strategies
Current Drug Targets - Inflammation & Allergy Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease
Current Pharmaceutical Design Hypoxia Upregulates MAPK<sup>p38</sup>/MAPK<sup>ERK</sup> Phosphorylation In Vitro: Neuroimmunological Differential Time-Dependent Expression of MAPKs
Protein & Peptide Letters Anti-Degenerative Effect of Melatonin on Intervertebral Disc: Protective Contribution against Inflammation, Oxidative Stress, Apoptosis, and Autophagy
Current Drug Targets Design of New Oxazaphosphorine Anticancer Drugs
Current Pharmaceutical Design The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity
Current Drug Metabolism Predicting Cell Association of Surface-Modified Nanoparticles Using Protein Corona Structure - Activity Relationships (PCSAR)
Current Topics in Medicinal Chemistry High Resolution Molecular Analysis as Tool for Evaluation of Arthritis Pathology
Current Rheumatology Reviews Gene Expression Profiling Analysis to Identify Key Genes and Underlying Mechanisms in Meniscus of Osteoarthritis Patients
Combinatorial Chemistry & High Throughput Screening Epidemiology of Psoriasis
Current Drug Targets - Inflammation & Allergy Structural, Functional and Therapeutic Aspects of Snake Venom Metalloproteinases
Mini-Reviews in Organic Chemistry Patent Annotations
Recent Patents on Cardiovascular Drug Discovery Mechanisms of CTLA-4-Ig in Tolerance Induction
Current Pharmaceutical Design Editorial [Hot Topic: Genome and Proteome Analyses of Autoimmune Diseases (Executive Editor: G. Neeck)]
Current Pharmaceutical Design Arginyl Aminopeptidase-Like 1 (RNPEPL1) Is an Alternatively Processed Aminopeptidase with Specificity for Methionine, Glutamine, and Citrulline Residues
Protein & Peptide Letters Hydrogen Sulfide-Based Anti-Inflammatory and Chemopreventive Therapies: An Experimental Approach
Current Pharmaceutical Design Anti-Inflammatory Approaches that Target the Chemokine Network
Recent Patents on Inflammation & Allergy Drug Discovery Using Alendronic Acid Coupled Fluorescently Labelled SM Liposomes as a Vehicle for Bone Targeting
Current Pharmaceutical Design Macrocyclic Histone Deacetylase Inhibitors
Current Topics in Medicinal Chemistry